Cargando…

Patient-Reported Outcomes (PROs) in COPD Clinical Trials: Trends and Gaps

Key characteristics of chronic obstructive pulmonary disease (COPD) that significantly affect health-related quality of life (HRQoL) include chest symptoms, dyspnea, cough, sputum production, and exacerbations. Additional areas of impact are sleep, fatigue, emotional well-being, social functioning,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Afroz, Nuzhat, Gutzwiller, Florian S, Mackay, Alex J, Naujoks, Christel, Patalano, Francesco, Kostikas, Konstantinos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398869/ https://www.ncbi.nlm.nih.gov/pubmed/32801678 http://dx.doi.org/10.2147/COPD.S235845

Ejemplares similares

Measuring What Matters for Children: A Systematic Review of Frequently Used Pediatric Generic PRO Instruments
por: Arsiwala, Tasneem, et al.
Publicado: (2021)

Performance of the Cough and Sputum Assessment Questionnaire (CASA-Q) in COPD: Evidence from Clinical and Online Patient Interaction Studies
por: Patalano, Francesco, et al.
Publicado: (2022)

Blood Eosinophils as Biomarkers to Drive Treatment Choices in Asthma and COPD
por: Kostikas, Konstantinos, et al.
Publicado: (2018)

The asthma–COPD overlap syndrome: do we really need another syndrome in the already complex matrix of airway disease?
por: Kostikas, Konstantinos, et al.
Publicado: (2016)

Early Clinically Important Improvement (ECII) and Exacerbation Outcomes in COPD Patients
por: Kostikas, Konstantinos, et al.
Publicado: (2020)

Impact of baseline symptoms and health status on COPD exacerbations in the FLAME study
por: Mackay, Alexander J., et al.
Publicado: (2020)

Gathering Structured Patient Insight to Drive the PRO Strategy in COPD: Patient-Centric Drug Development from Theory to Practice
por: Patalano, Francesco, et al.
Publicado: (2019)

Treatment response in COPD: does FEV(1) say it all? A post hoc analysis of the CRYSTAL study
por: Kostikas, Konstantinos, et al.
Publicado: (2019)

Impact of COPD diagnosis timing on clinical and economic outcomes: the ARCTIC observational cohort study
por: Larsson, Kjell, et al.
Publicado: (2019)

Real-world retrospective cohort study ARCTIC shows burden of comorbidities in Swedish COPD versus non-COPD patients
por: Ställberg, Björn, et al.
Publicado: (2018)

LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysis
por: Rodrigo, Gustavo J, et al.
Publicado: (2017)

Evaluation of exacerbations and blood eosinophils in UK and US COPD populations
por: Vogelmeier, Claus F., et al.
Publicado: (2019)

Efficacy and safety of direct switch to indacaterol/glycopyrronium in patients with moderate COPD: the CRYSTAL open-label randomised trial
por: Vogelmeier, Claus F., et al.
Publicado: (2017)

Indacaterol/glycopyrronium versus salmeterol/fluticasone in the prevention of clinically important deterioration in COPD: results from the FLAME study
por: Anzueto, Antonio R., et al.
Publicado: (2018)

Patient-reported outcome measures in presbyopia: a literature review
por: Sharma, Garima, et al.
Publicado: (2020)

Effect of indacaterol/glycopyrronium on ventilation and perfusion in COPD: a randomized trial
por: Singh, Dave, et al.
Publicado: (2022)

Evaluation of the content validity of patient-reported outcome (PRO) instruments developed for use with individuals with phakic presbyopia, including the Near Activity Visual Questionnaire-presbyopia (NAVQ-P) and the near vision correction independence (NVCI) instrument
por: Bentley, Sarah, et al.
Publicado: (2021)

Patients' perspectives on COPD: findings from a social media listening study
por: Cook, Nigel S., et al.
Publicado: (2019)

Exacerbation heterogeneity in COPD: subgroup analyses from the FLAME study
por: Vogelmeier, Claus F, et al.
Publicado: (2018)

Clinical Impact and Healthcare Resource Utilization Associated with Early versus Late COPD Diagnosis in Patients from UK CPRD Database
por: Kostikas, Konstantinos, et al.
Publicado: (2020)

The Perception of Physicians on Gender-Specific Differences in the Diagnosis of COPD: Results from a Questionnaire-Based Survey
por: Raherison-Semjen, Chantal, et al.
Publicado: (2021)

Understanding the visual function symptoms and associated functional impacts of phakic presbyopia
por: Bentley, Sarah, et al.
Publicado: (2021)

Development of Novel Patient-Reported Outcome (PRO) and Observer-Reported Outcome (ObsRO) Instruments in Retinitis Pigmentosa (RP) and Leber Congenital Amaurosis (LCA): ViSIO-PRO and ViSIO-ObsRO
por: Audo, Isabelle, et al.
Publicado: (2023)

"Show me the money": a fair criticism of economic studies on inhaled bronchodilators for COPD
por: Kostikas, Konstantinos, et al.
Publicado: (2010)

Indacaterol/glycopyrronium reduces the risk of clinically important deterioration after direct switch from baseline therapies in patients with moderate COPD: a post hoc analysis of the CRYSTAL study
por: Greulich, Timm, et al.
Publicado: (2018)

Hypercoagulable State in COPD-A Comprehensive Literature Review
por: Kyriakopoulos, Christos, et al.
Publicado: (2021)

Pulmonary biomarkers in COPD exacerbations: a systematic review
por: Koutsokera, Angela, et al.
Publicado: (2013)

Comparison of Literature Review, Social Media Listening, and Qualitative Interview Research Methods in Generating Patient-Reported Symptom and Functional Impact Concepts of Presbyopia
por: Findley, Amy, et al.
Publicado: (2022)

Patient Reported Outcomes (PROs) in Clinical Trials: Is ‘In-Trial’ Guidance Lacking? A Systematic Review
por: Kyte, Derek G., et al.
Publicado: (2013)

Patient-Reported Outcomes (PROs) and Patient-Reported Outcome Measures (PROMs)
por: Weldring, Theresa, et al.
Publicado: (2013)

Addressing unmet needs in the treatment of COPD
por: Patalano, Francesco, et al.
Publicado: (2014)

Correction: Patient Reported Outcomes (PROs) in Clinical Trials: Is ‘In-Trial’ Guidance Lacking? A Systematic Review
por: Kyte, Derek G., et al.
Publicado: (2014)

Pros & Cons
por: Herr, Yeek
Publicado: (2011)

Open peer review: pros and cons
por: Sardanelli, Francesco, et al.
Publicado: (2023)

Focus on Silodosin: Pros and Cons of Uroselectivity
por: Califano, Gianluigi, et al.
Publicado: (2020)

Inhaled corticosteroid use by exacerbations and eosinophils: a real-world COPD population
por: Vestbo, Jørgen, et al.
Publicado: (2019)

Patient-reported outcomes (PROs) in randomised controlled trials in diabetes and pregnancy: protocol for a systematic review
por: Newman, Christine, et al.
Publicado: (2021)

Supercollider: Pros and cons
Publicado: (1993)

The Pros of Not Being Competitive
por: MUTEL, VINCENT, et al.
Publicado: (2007)

Circumcision: Pros and cons
por: Burgu, Berk, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_h1lnftv5tqend388c7iri2dflv